Semaglutide is a medication that belongs to a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). It is primarily used for the treatment of type 2 diabetes and obesity. Semaglutide is a synthetic version of a naturally occurring hormone called glucagon-like peptide-1 (GLP-1), which is produced in the intestine in response to food intake.
GLP-1 plays several important roles in regulating blood sugar levels and metabolism. It stimulates the release of insulin from the pancreas, which helps lower blood sugar levels after meals. It also reduces the secretion of glucagon, a hormone that raises blood sugar levels, and it slows down the rate at which food is emptied from the stomach, leading to a sense of fullness and reduced appetite.
Semaglutide mimics the effects of GLP-1 in the body, but it is a longer-lasting and more stable form that can be administered through injections. It is available in different formulations, including a once-weekly injection, which provides continuous GLP-1 receptor activation over an extended period.
Semaglutide helps lower blood sugar levels in people with type 2 diabetes.
Semaglutide does this by promoting insulin secretion inhibiting glucagon release, and slowing gastric emptying. It can be used as a monotherapy or in combination with other diabetes medications.
Injectable medications like semaglutide can be helpful for people with type 2 diabetes. Semaglutide belongs to a class of drugs known as glucagon-like peptide-1 receptor agonists (GLP-1 RAs), which have shown to be effective in managing blood sugar levels in individuals with type 2 diabetes.
How effective is semaglutide for weight loss in non-diabetics?
Semaglutide has also been approved for the treatment of obesity. In this context, it’s used to help with weight loss by reducing appetite and increasing feelings of satiety.
Semaglutide is available in a once-weekly injection form. This dosing frequency is more convenient for many patients compared to daily medications, making it easier for them to adhere to their treatment regimen.
When Semaglutide is injected, it binds to and activates GLP-1 receptors in the pancreas, which stimulates the release of insulin from beta cells in the pancreas. Insulin helps lower blood sugar levels by moving glucose from the bloodstream into the body’s cells, where it can be used for energy. Semaglutide also works by slowing down the rate at which food is digested and absorbed in the stomach, which can help regulate blood sugar levels and reduce appetite. This effect can be particularly helpful in individuals with type 2 diabetes who struggle with weight management.
Some GLP-1 RAs, including Semaglutide, have demonstrated cardiovascular benefits in clinical trials.
They have been associated with reduced risks of major adverse cardiovascular events (MACE), such as heart attack and stroke, in people with type 2 diabetes who are at risk for these complications.
Semaglutide’s mechanism of action is such that it lowers blood sugar without significantly increasing the risk of hypoglycemia (dangerously low blood sugar levels). This is a crucial consideration when managing diabetes, as hypoglycemia can be a serious and potentially life-threatening complication.
While all medications have potential side effects, the safety profile of Semaglutide has been generally favorable. Like any medication, it’s important for individuals to discuss potential risks and benefits with their healthcare providers.
We offer Semaglutide IV injections for 499/month
Includes the cost of the medicine, 4 weekly injections, a B12 shot on your 3rd week and the monthly consult with our Nurse Practitioner. Book Your Treatment.